Fulvestrant plus capivasertib versus placebo in metastatic ER positive breast cancer (FAKTION): a randomised, double-blind, placebo-controlled, phase II trial
Carucci, M Casbard, A Cox, C Butler, R Alchami, F Bale, C Bezecny, P Joffe, J Moon, S
Carucci, M
Casbard, A
Cox, C
Butler, R
Alchami, F
Bale, C
Bezecny, P
Joffe, J
Moon, S
Citations
Altmetric:
Abstract
Affiliation
Description
Date
2020
Publisher
Collections
Keywords
Type
Meetings and Proceedings
Citation
Howell SJ, Carucci M, Casbard A, Cox C, Butler R, Alchami F, et al. Fulvestrant plus capivasertib versus placebo in metastatic ER positive breast cancer (FAKTION): a randomised, double-blind, placebo-controlled, phase II trial. Breast Cancer Research and Treatment. 2020;180:530-1